Echo-guided percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: 7 years of experience

European Journal of Echocardiography

Volumn 5, Issue 5, 2004, Pages 347-355

  Faber, Lothar ^a   Seggewiss, Hubert ^b   Welge, Dirk ^a   Fassbender, Dieter ^a   Schmidt, Henning K ^a   Gleichmann, Ulrich ^a   Horstkotte, Dieter ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b Leopoldina Hospital   (Germany)

Author keywords

Hypertrophic obstructive cardiomyopathy; Left ventricular outflow tract gradient; Myocardial contrast echocardiography; Percutaneous septal ablation

Indexed keywords

ALCOHOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; OXYGEN; VERAPAMIL;

ADOLESCENT; ADULT; AGED; ARTICLE; BALLOON OCCLUSION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; EXERCISE TOLERANCE; FEMALE; HEART CATHETERIZATION; HEART MUSCLE OXYGEN CONSUMPTION; HEART PACING; HOSPITALIZATION; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; IMAGE ANALYSIS; INTERVENTIONAL RADIOLOGY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUSCLE RESECTION; PATIENT MONITORING; PATIENT SELECTION; PRIORITY JOURNAL; SYMPTOMATOLOGY; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT INDICATION;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOMYOPATHY, HYPERTROPHIC; CHEMOEMBOLIZATION, THERAPEUTIC; CONTRAST MEDIA; ECHOCARDIOGRAPHY; ETHANOL; FEMALE; HEART CATHETERIZATION; HEART SEPTUM; HUMANS; MALE; MIDDLE AGED; POLYSACCHARIDES; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL; VENTRICULAR OUTFLOW OBSTRUCTION;

EID: 4444319206     PISSN: 15252167     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euje.2004.01.001     Document Type: Article

References (20)

1. Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy Lancet 346 1995 211-214
2. Knight C.J. Kurbaan A.S. Seggewiss H. Henein M. Gunning M. Harrington D. et al. Non-surgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients Circulation 95 1997 2075-2081
3. Braunwald E. Induced septal infarction: a new strategy for hypertrophic obstructive cardiomyopathy Circulation 95 1997 1981
4. Kuhn H. Gietzen F. Leuner C. Gerenkamp T. Induction of subaortic septal ischemia to reduce obstruction in hypertrophic obstructive cardiomyopathy Eur Heart J 18 1997 846-851
5. Seggewiss H. Gleichmann U. Faber L. Fassbender D. Schmidt H.K. Strick S. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-months-follow-up in 25 patients J Am Coll Cardiol 31 1998 252-258
6. Faber L, Seggewiss H, Fassbender D, Strick S, Bogunovic N, Gleichmann U. Guiding of interventional myocardial ablation in obstructive hypertrophic cardiomyopathy by myocardial contrast echocardiography: first experiences. Eighth Essen-Mayo-Mainz Symposium, Essen, October 1996.
7. Faber L. Seggewiss H. Fassbender D. Strick S. Gleichmann U. Guiding of PTSMA in obstructive hypertrophic cardiomyopathy by myocardial contrast echocardiography: a case report J Interv Cardiol 11 1998 443-448
8. Lakkis N.M. Nagueh S.F. Kleiman N.S. Killip D.M. He Z.X. Verani M. et al. Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy Circulation 98 1998 1750-1755
9. Faber L. Seggewiss H. Gleichmann U. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intra-procedural myocardial contrast echocardiography Circulation 98 1998 2415-2421
10. Faber L. Seggewiss H. Ziemssen P. Targeting percutaneous transluminal septal ablation for HOCM by intra-procedural echocardiographic monitoring J Am Soc Echocardiogr 13 2000 1074-1079
11. Wigle D.E. Rakowski H. Kimball B.P. Williams W.G. Hypertrophic cardiomyopathy: clinical spectrum and treatment Circulation 92 1995 1680-1692
12. Elliott P.M. Poloniecki J. Dickie S. Sharma S. Monserrat M. Varnava A. et al. Sudden death in HCM: identification of high risk patients J Am Coll Cardiol 36 2000 2212-2218
13. Seggewiss H. Current status of alcohol septal ablation for patients with hypertrophic obstructive cardiomyopathy Curr Cardiol Rep 3 2001 160-166
14. Gietzen F.H. Leuner C.J. Raute-Kreinsen U. Dellmann A. Hegselmann J. Strunk-Mueller C. et al. Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH) Eur Heart J 20 1999 1342-1354
15. Faber L. Meissner A. Ziemssen P. Seggewiss H. Percutaneous transluminal septal myocardial ablation for HOCM: long-term follow-up in the first series of 25 patients Heart 83 2000 326-331
16. Kizilbash A.M. Heinle S.K. Grayburn P.A. Spontaneous variability of left ventricular outflow tract gradients in hypertrophic obstructive cardiomyopathy Circulation 97 1998 461-466
17. Singh M. Edwards W.D. Holmes D.R. Tajik A.J. Nishimura R.A. Anatomy of the first septal perforating artery: a study with implications for ablation therapy for HCM Mayo Clin Proc 76 2001 799-802
18. Mayer S.A. Anwar A. Grayburn P.A. Comparison of successful and failed alcohol septal ablations for obstructive hypertrophic cardiomyopathy Am J Cardiol 92 2 2003 241-242
19. Gietzen F.H. Leuner C.J. Obergassel L. Strunk-Mueller C. Kuhn H. Role of transcoronary ablation of septal hypertrophy in patients with hypertrophic cardiomyopathy, New York Heart Association functional class III or IV, and outflow obstruction only under provocable conditions Circulation 106 2002 454-459
20. ACC/ESC consensus group on hypertrophic cardiomyopathy Eur Heart J 24 2003 1965-1991